Form 4/A for CME CME Group
Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-15 · accession 0001156375-24-000182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-09-18 | 2024-09-16 | CME | Fitzpatrick Lynne | Sr MD CFO | A - Grant | $218.53 | +3,604 | 16.9K | +27% | +$787.6K |
| A | 2024-09-18 | 2024-09-15 | CME | Fitzpatrick Lynne | Sr MD CFO | F - Tax | $216.99 | -754 | 13.3K | -5% | -$163.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2024-09-16 | A | A | 3,604 | $218.53 | 16,865 | D | — | — | |
| 2 | Common | Common Stock Class A | 2024-09-15 | F | D | 754 | $216.99 | 13,261 | D | — | — | (F2) Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2024. |